The prognostic value and potential mechanism of Matrix Metalloproteinases among Prostate Cancer
Authors:
Open Access
- 1 January 2020
- journal article
- research article
- Published by Ivyspring International Publisher in International Journal of Medical Sciences
- Vol. 17 (11) , 1550-1560
Abstract
Background: Matrix Metalloproteinases (MMPs) play an indispensable role in the initial alteration and development of PCa. We tried to generate an MMP-related prognostic signature (MMPS) in prostate cancer (PCa).Keywords
This publication has 38 references indexed in Scilit:
- A new transcriptional role for matrix metalloproteinase-12 in antiviral immunityNature Medicine, 2014
- Updated Prognostic Model for Predicting Overall Survival in First-Line Chemotherapy for Patients With Metastatic Castration-Resistant Prostate CancerJournal of Clinical Oncology, 2014
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortalScience Signaling, 2013
- International Variation in Prostate Cancer Incidence and Mortality RatesEuropean Urology, 2012
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics DataCancer Discovery, 2012
- New and Paradoxical Roles of Matrix Metalloproteinases in the Tumor MicroenvironmentFrontiers in Pharmacology, 2012
- Characterising the castration-resistant prostate cancer population: a systematic reviewInternational Journal Of Clinical Practice, 2011
- Matrix Metalloproteinases: Regulators of the Tumor MicroenvironmentCell, 2010
- Progress in matrix metalloproteinase researchMolecular Aspects of Medicine, 2008
- Structure and function of matrix metalloproteinases and TIMPsCardiovascular Research, 2006